Mark H. Schoenfisch

Mark H. Schoenfisch, Peter A. Ornstein Distinguished Professor at the University of North Carolina at Chapel Hill, is a leading researcher in analytical chemistry and biomedical engineering. Jointly appointed with the School of Medicine and School of Pharmacy, he focuses on nitric oxide-based therapeutics and biosensor development.

• B.Sc. University of Kansas (1992)
• Ph.D. University of Arizona (1997)
• National Institutes of Health Postdoctoral Fellow (1998-1999)

Research Interests center on four key areas:

• Nitric oxide delivery vehicles for therapeutic applications
• Implantable glucose monitoring systems
• Microfluidic NO detection in biological environments
• Superhydrophobic surfaces for microbial prevention

Scientific Contributions appear in Anal Chem, J Am Chem Soc, and Adv Healthc Mater, with recent work on NO-releasing nanoparticles for cancer therapy and biofilm disruption in chronic infections.

Awards & Recognitions:

• NSF CAREER Award (2004-2009)
• Eli Lilly Young Investigator Award (2002-2004)
• Chapman Family Teaching Award (2015)
• International Union of Pure and Applied Chemistry Young Observer (2005)

Lab Leadership includes mentoring graduate researchers in the Schoenfisch Group, with ongoing projects in diabetic wound healing and antibiotic-resistant bacterial treatment.